Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neuroscience Letters

• Publication date

  1998-07-31

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0304-3940(98)00504-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

  1998cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

  1997cited by this paper
• Identification of two distinct synucleins from human brain

  1994cited by this paper
• Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy.

  1992cited by this paper
• Oligodendroglial Microtubular Tangles in Olivopontocerebellar Atrophy

  1990cited by this paper
• A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

  1990cited by this paper
• Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

  1989cited by this paper
• Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.

  1969cited by this paper

• Effect of sequence variations on the phase behavior of a functional IDP fragment.

  2026cites this paper
• Interactions Between Nutraceuticals and α-Synuclein Conformational States: Molecular Mechanisms and Neuroprotective Implications in Parkinson’s Disease

  2026cites this paper
• Green tea polyphenol EGCG acts differentially on end-stage amyloid polymorphs of α-synuclein formed in different polyol osmolytes.

  2025cites this paper
• Longitudinal brain morphometry in Parkinson’s disease clinical subtypes: Distinct signatures forecast behavioral change within subtypes

  2025cites this paper
• Characteristics of cerebral glucose metabolism in patients with cognitive impairment in multiple system atrophy

  2025cites this paper
• Evidence of a novel α-synuclein strain isolated from a Parkinson’s disease with dementia patient sample

  2025cites this paper
• Altered gut microbial networks and metabolic pathways in multiple system atrophy: a comparative 16S rRNA study

  2025cites this paper
• Evaluation of 6 monoclonal antibodies against Ser129-phosphorylated α-synuclein: Critical role of proteinase K antigen retrieval and superior sensitivity of the D1R1R clone in human skin biopsies.

  2025cites this paper
• Surface wetting is a key determinant of α-synuclein condensate maturation

  2025cites this paper
• α-Synuclein condensation in synaptic vesicle function and synucleinopathies.

  2025cites this paper
• Lipidic folding pathway of α-Synuclein via a toxic oligomer

  2025influential citation
• PET tracer development for imaging α-synucleinopathies

  2025cites this paper
• Age-dependent progression from clearance to vulnerability in the early response of periventricular microglia to α-synuclein toxic species

  2025cites this paper
• Fluorescent probes for α-synuclein biomarkers: Innovations in early diagnosis and therapeutic monitoring of Parkinson's disease.

  2025cites this paper
• Intracellular Inclusions Induced by Patient-Derived and Amplified α-Synuclein Aggregates Are Morphologically Indistinguishable

  2025cites this paper
• Surface-enhanced Raman scattering for the detection of biomarkers of neurodegenerative diseases: A review

  2025cites this paper
• Hidden faces of alpha-synuclein: Cryo-EM revelation of fibril polymorphs driven by disease, mutations, and PTMs

  2025cites this paper
• Intranasal administration of ergothioneine improves memory in a mouse model of multiple system atrophy.

  2025cites this paper
• Skin-derived α-synuclein strains from PD, DLB, and MSA induce distinct intracellular pathology and neurodegeneration

  2025cites this paper
• Structural polymorphism of α-synuclein fibrils alters the pathway of Hsc70-mediated disaggregation

  2025cites this paper
• Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research

  2025cites this paper
• Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies

  2024cites this paper
• Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications

  2024cites this paper
• Analysis and comparison of post-translational modifications of α-synuclein filaments in multiple system atrophy and dementia with Lewy bodies

  2024cites this paper
• Structurally targeted mutagenesis identifies key residues supporting α-synuclein misfolding in multiple system atrophy

  2024cites this paper
• 4-Oxo-2-Nonenal- and Agitation-Induced Aggregates of α-Synuclein and Phosphorylated α-Synuclein with Distinct Biophysical Properties and Biomedical Applications

  2024cites this paper
• Cryo‐EM structure of a novel α‐synuclein filament subtype from multiple system atrophy

  2024cites this paper
• Associations between gut microbiota characteristics and non‐motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients

  2024cites this paper
• Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice

  2024cites this paper
• In Vitro Cell Model Investigation of Alpha-Synuclein Aggregate Morphology Using Spectroscopic Imaging

  2024cites this paper
• Role of Lipids in the Pathogenesis of Parkinson’s Disease

  2024cites this paper
• Evidence for prodromal changes in neuronal excitability and neuroinflammation in the hippocampus in young alpha-synuclein (A30P) transgenic mice

  2024cites this paper
• Lipids and α-Synuclein: adding further variables to the equation

  2024cites this paper
• Oligodendrocytes, the Forgotten Target of Gene Therapy

  2024cites this paper
• Synthetic β-sheets mimicking fibrillar and oligomeric structures for evaluation of spectral X-ray scattering technique for biomarker quantification

  2024cites this paper
• The role of α-synuclein prion strains in Parkinson’s disease and multiple system atrophy

  2024cites this paper
• Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders

  2024cites this paper
• Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins

  2024cites this paper
• Cross-Linked α-Synuclein as Inhibitor of Amyloid Formation

  2023cites this paper
• Sarkosyl differentially solubilizes patient-derived alpha-synuclein fibril strains

  2023cites this paper
• Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity

  2023cites this paper
• RNA sequestration driven by amyloid formation: the alpha synuclein case

  2023cites this paper
• Genome-wide CRISPR–Cas9 Knockout Screening Reveals a TSPAN3-mediated Endo-lysosome Pathway Regulating the Degradation of α-Synuclein Oligomers

  2023cites this paper
• Truncation or proteolysis of α-synuclein in Parkinsonism.

  2023cites this paper
• The Structural Combination of SIL and MODAG Scaffolds Fails to Enhance Binding to α-Synuclein but Reveals Promising Affinity to Amyloid β

  2023cites this paper
• Ultrastructures of α-Synuclein Filaments in Synucleinopathy Brains and Experimental Models

  2023cites this paper
• RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions

  2023cites this paper
• Protein aggregation-inhibition: a therapeutic route from Parkinson’s disease to sickle cell anemia

  2023cites this paper
• Cellular processing of α-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114

  2023cites this paper
• A Computational Approach Reveals the Ability of Amyloids to Sequester RNA: the Alpha Synuclein Case

  2023cites this paper
• Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface.

  2023cites this paper
• Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease

  2023cites this paper
• A functional role for alpha-synuclein in neuroimmune responses.

  2023cites this paper
• Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson’s disease-related fibril polymorphism

  2023cites this paper
• White and gray matter alterations in de novo PD patients: which matter most?

  2023cites this paper
• iPSC-Derived Striatal Medium Spiny Neurons from Patients with Multiple System Atrophy Show Hypoexcitability and Elevated α-Synuclein Release

  2023cites this paper
• Urinary tract infections trigger synucleinopathy via the innate immune response

  2023cites this paper
• Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson’s Disease—Potential Biomarkers and Therapeutic Targets

  2023cites this paper
• Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology

  2023cites this paper
• α-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases.

  2023cites this paper
• α-synuclein as a potential biomarker for developing diagnostic tools against neurodegenerative disorders

  2023cites this paper
• An overview on pure autonomic failure.

  2023cites this paper
• Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases

  2023cites this paper
• ⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and Humans

  2023cites this paper
• Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease.

  2022cites this paper
• Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

  2022cites this paper
• A Facile Method to Produce N-Terminally Truncated α-Synuclein

  2022cites this paper
• Body-first Parkinson's disease and variant Creutzfeldt-Jakob disease - similar or different?

  2022cites this paper
• Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models

  2022cites this paper
• Yeast red pigment, protein aggregates, and amyloidoses: a review

  2022cites this paper
• Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy

  2022cites this paper
• Multiple system atrophy

  2022cites this paper
• Atrophie multisystématisée

  2022cites this paper
• The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease

  2022cites this paper
• Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

  2022influential citation
• New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy

  2022cites this paper
• Atrofia multisistemica

  2022cites this paper
• Mechanisms Underlying Neurodegenerative Disorders and Potential Neuroprotective Activity of Agrifood By-Products

  2022cites this paper
• Ingenuity pathway analysis of α-synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseases

  2022cites this paper
• Structures of α-synuclein filaments from human brains with Lewy pathology

  2022cites this paper
• Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo

  2022cites this paper
• Skeletal Muscle is a Source of α-Synuclein with a Sarcolemmal Non-Lipid Raft Distribution.

  2022cites this paper
• Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human α-synuclein

  2022influential citation
• A Theoretical Model reveals RNA sequestration in Alpha Synuclein Aggregates

  2022cites this paper
• An overview on microglial origin, distribution, and phenotype in Alzheimer's disease

  2022cites this paper
• Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats

  2022cites this paper
• Genetically Encoded Aryl Alkyne for Raman Spectral Imaging of Intracellular α-Synuclein Fibrils.

  2022cites this paper
• Molecular mechanism for the synchronized electrostatic coacervation and co-aggregation of alpha-synuclein and tau

  2022cites this paper
• Structures of tau and α-synuclein filaments from brains of patients with neurodegenerative diseases.

  2022cites this paper
• Plasticity of Membrane Binding by the Central Region of α-Synuclein

  2022cites this paper
• Macroscopic diagnostic clue for parkinsonism

  2022cites this paper
• Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy.

  2022cites this paper
• Microorganisms associated with increased risk of Parkinson's disease.

  2022cites this paper
• Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants

  2022cites this paper
• Exosome: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics

  2022cites this paper
• Association of p53 with Neurodegeneration in Parkinson's Disease

  2022cites this paper
• Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies

  2022cites this paper
• Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders

  2022cites this paper
• Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model

  2022cites this paper
• Dysmetabolism and Neurodegeneration: Trick or Treat?

  2022cites this paper